𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Commentary on “Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.” Aizer AA, Chen MH, Hattangadi J, D'Amico AV. Harvard Radiation Oncology program, Boston, MA.

✍ Scribed by Ritter, Mark A.

Book ID
125474840
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
107 KB
Volume
32
Category
Article
ISSN
1078-1439

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intermediate end point for prostate canc
Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure. D'Amico AV, Moul JW, Carroll PR, Cote K, Sun L, Lubeck D, Renshaw AA, Loffredo M, Chen MH, Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA.: J Natl Cancer Inst 2004;96:509–15
✍ Donald L. Trump 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 22 KB
Intermediate end point for prostate canc
Intermediate end point for prostate cancer-specific mortality following salvage hormonal therapy for prostate-specific antigen failure: D’Amico AV, Moul JW, Carroll PR, Cote K, Sun L, Lubeck D, Renshaw AA, Loffredo M, Chen MH, Department of Radiation Oncology, Brigham and Women’s Hospital and Dana-Farber Cancer Institute, Boston, MA. J Natl Cancer Inst 2004;96:509–15
✍ Gurkamal Chatta 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 42 KB
Commentary on “Impact of postoperative p
Commentary on “Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death”. Choueiri TK, Chen MH, D'Amico AV, Sun L, Nguyen PL, Hayes JH, Robertson CN, Walther PJ, Polascik TJ, Albala DM, Moul JW, Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA: Cancer 2010;116:1887–92
✍ Mark A. Ritter 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 65 KB